The effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised rats
International Journal of Medical Sciences · 2023
DOI: 10.7150/ijms.84604 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2023. Verfasst von Sophia Ogechi Ekeuku und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysiaa, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Bone Marrow, Adiposity. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Menopause is accompanied by increased oxidative stress, partly contributing to weight gain and bone marrow adiposity. Traditional Chinese medication, E'Jiao, has been demonstrated to reduce excessive bone remodelling during oestrogen deprivation, but its effects on body composition and bone marrow adiposity during menopause remain elusive.
Objective
To determine the effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised (OVX) rats.
Methods
Seven groups of three-month-old female Sprague Dawley rats were established (n=6/group): baseline, sham, OVX control, OVX-treated with low, medium or high-dose E'Jiao (0.26, 0.53, 1.06 g/kg, p.o.) or calcium carbonate (1% in tap water, ad libitum). The supplementation was terminated after 8 weeks. Whole-body composition analysis was performed monthly using dual-energy X-ray absorptiometry. Analysis of bone-marrow adipocyte numbers and skeletal antioxidant activities were performed on the femur.
Results
Increased total mass, lean mass, and bone marrow adipocyte number were observed in the OVX control versus the sham group. Low-dose E'Jiao supplementation counteracted these changes. Besides, E'Jiao at all doses increased skeletal catalase and superoxide dismutase activities but lowered glutathione levels in the OVX rats. Skeletal malondialdehyde level was not affected by ovariectomy but was lowered with E'Jiao supplementation. However, peroxisome proliferator-activated receptor gamma protein expression was not affected by ovariectomy or any treatment.
Conclusion
E'Jiao, especially at the low dose, prevented body composition changes and bone marrow adiposity due to ovariectomy. These changes could be mediated by the antioxidant actions of E'Jiao. It has the potential to be used among postmenopausal women to avoid adiposity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysiaa, Kuala Lumpur, Malaysia.
- Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China.
- Department of Anatomy, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
Zitieren
APA
Ekeuku, S. O., Chin, K. Y., Qian, J., Zhang, Y., Qu, H., Ahmad, F., Wong, S. K., Noor, M. M. M., & Soelaiman, I. N. (2023). The effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised rats. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.84604
Vancouver
Ekeuku SO, Chin KY, Qian J, Zhang Y, Qu H, Ahmad F, et al. The effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised rats. International Journal of Medical Sciences. 2023. doi:10.7150/ijms.84604
BibTeX
@article{Ekeuku2023,
author = {Ekeuku, Sophia Ogechi and Chin, Kok-Yong and Qian, Jing and Zhang, Yan and Qu, Haibin and Ahmad, Fairus and Wong, Sok Kuan and Noor, Mohd Mustazil Mohd and Soelaiman, Ima Nirwana},
title = {The effects of E'Jiao on body composition, bone marrow adiposity and skeletal redox status in ovariectomised rats},
journal = {International Journal of Medical Sciences},
year = {2023},
doi = {10.7150/ijms.84604}
}
EUVIMED